Record #19988
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro
Publisher
Original paper date
Feb 7, 2005
Original DOI
Notes from Retraction Watch
see also: https://pubpeer.com/publications/BD8D3DAC5589D61182426032C47333;
Citation lifecycle
How this paper is being cited
Pre-retraction
37
Same day
0
Post-retraction
1
% post-retraction
2.6%
~2.6 citations/yr before retraction · ~0.1 citations/yr after
— citing papers
Who is still citing this work
Loading…